학술논문
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Single and MultipleAscending Dose Study of AMG 133 in Subjects with Obesity: Late Breaking: A Phase 1 Study of AMG 133 in Subjects with Obesity
Document Type
Abstract
Author
Source
In Metabolism May 2023 142 Supplement
Subject
Language
ISSN
0026-0495